HCA Healthcare cancer institute implements CAR T-cell Therapy outpatient model

February 26, 2024- HCA Healthcare, Inc. announced that the Sarah Cannon Cancer Institute (SCCI) of HCA Healthcare has successfully established an integrated management process that safely transitioned more than 75% of HCA Healthcare’s CAR T-cell therapy patients into an outpatient setting for monitoring. The program model resulted in more than 1,200 hospital bed days saved for the first 100 patients of the program compared to historical results, and approximately 20% of patients avoided hospitalization altogether.

Learn More

safe online pharmacy for viagra cheap kamagra oral jelly online